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1. Introduction  
Surveillance is becoming common in the practice of colonoscopy because a large number of 
patients with colorectal polyps are now being discovered as a result of the increased use of 
colorectal cancer screening, and particularly because of the dramatic increase in screening 
colonoscopy. Although the term ‘colorectal polyp’ is not synonymous with colorectal 
adenoma, two-thirds of colorectal polyps are adenomas and most colorectal cancers arise 
from them. Therefore, removal of colorectal polyps using colonoscopic polypectomy has 
been shown to reduce the risk of future colorectal cancer (Winawer et al., 1993; Atkin et al., 
2010). 
A patient with one colorectal adenoma has a 30 to 50% likelihood of harboring a second 
synchronous adenoma elsewhere in the colon and rectum at that time, and they have a 30-
50% likelihood of developing metachronous adenoma sometime in the future (Winawer et 
al., 2006; Arditi et al., 2009). Therefore, to minimize the risk for colorectal cancer in the 
future, patients with adenomas are usually placed into a post-polypectomy surveillance 
program.  
Post-polypectomy surveillance refers to periodically examining the colon to detect and 
remove missed synchronous and new metachronous adenomas and cancers, by screening or 
other means, after the detection and removal of a precancerous lesion. Generally, it does not 
refer to the use of colonoscopy or other procedures to monitor for polyp or cancer 
recurrence following a diagnosis of colorectal cancer.   
This chapter reviews the rationale, the recent literature and the current recommendations 
for post-polypectomy surveillance, with emphasizing the need to tailor surveillance 
strategies to the carefully considered individualized assessment of the risk factors as related 
to the characteristics of the baseline adenoma and those of the individual patient.  
2. Risk of colorectal adenoma or cancer following polypectomy 
The objective of post-polypectomy surveillance is to reduce the risk of the development of 
and death from a colorectal cancer by detecting and removing subsequent adenomas and 
cancers. The largest study on the risk of colorectal cancer after removal of adenoma in the 
colon or rectum was reported in 2010 from St. Mark’s Hospital, London by Atkin et al. and 
the study involved using flexible sigmoidoscopy screening (Atkin et al., 2010). After 113,195 
people were assigned to the control group and 57,237 people were assigned to the 
intervention group, they were followed for a median of 11.2 years. The incidence of 
colorectal cancer in the patients who underwent sigmoidoscopy was reduced by 23% 
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(hazard ratio: 0.77, 95% CI: 0.70-0.84) and mortality was reduced by 31% (hazard ratio: 0.69, 
CI: 0.59-0.82). On the per-protocol analyses, after adjusting for a self-selection bias for the 
patients who underwent sigmoidoscopy, the incidence of colorectal cancer in the people 
attending the screening was reduced by 33% (hazard ratio: 0.67, CI: 0.60-0.76) and the 
mortality was reduced by 43% (hazard ratio: 0.57, CI: 0.45-0.72). The relative colorectal 
cancer risk after polypectomy in all the previously published studies has ranged from 0.2 
(range: 0.1–0.6) in the National Polyp Study to 1.3 (range: 0.6–2.3) in the Funen Adenoma 
follow-up Study (Winawer et al., 1993; Meagher and Stuart 1994; Citarda et al., 2001; Lund 
et al., 2001; Bertario et al., 2003; Loeve et al., 2005; Atkin et al., 2010). The difference can 
partially be explained by the inclusion or exclusion of patients with large sessile polyps and 
other factors too such as the patient characteristics at baseline, the duration of follow-up, the 
patient compliance and the quality of the initial colonoscopy and polypectomy. The risk of 
colorectal cancer for patients after polypectomy is lower than that in the general population. 
2.1 Concept of the advanced adenoma as a surrogate marker of colorectal cancer  
Based on the studies on the prevalence of adenoma from autopsy, the studies on follow-up 
colonoscopy after polypectomy and the lifetime cumulative incidence of colorectal cancer, it 
appears that only about 5% of colorectal adenomas undergo malignant transformation 
(Muto et al., 1975; Stryker et al., 1987; Vogelstein et al., 1988; Center et al., 2009; Hong et al., 
2010). These follow-up experiences as well as the increasing information about the 
molecular genetics for the adenoma-carcinoma sequence are increasingly shifting the 
emphasis away from simply finding and harvesting large numbers of clinically insignificant 
adenomas toward strategies that focus on ways to reliably detect and resect the less 
common, but clinically much more dangerous advanced adenoma.  
Colorectal carcinogenesis is a multistep process that occurs over many years and it results 
from the progressive accumulation of genetic and epigenetic alterations. An adenoma is a 
monoclonal derivative of a single epithelial stem cell that either inherits or acquires the first 
of these many genetic alterations. Each additional genetic "hit," which is probably caused by 
environmental carcinogenic factors, leads to a new clone of daughter cells with a growth 
advantage that allows the clone to take over the developing polyp. The reason most small 
simple tubular adenomas stay small and clinically benign is because they never develop the 
additional genetic alterations needed to make them advance (Vogelstein et al., 1988).  
Observational studies also reported the different behavior of small tubular adenomas and 
advanced adenomas. Most previous studies of the natural history of small colorectal 
adenomas showed no increase in size, no changes that would have necessitated treatment 
within a couple of years and that malignant transformation is rare. Hoff et al. reported that 
215 polyps less than 5 mm in diameter were left in situ in 112 persons for a 2 year follow-up 
period to ascertain their growth rate. At the end of the 2 years, 49% of the adenomas had 
increased in size and 14% had regressed. Although the total adenoma mass had increased 
by 36%, none had grown to a size greater than 5mm and none had developed high-grade 
dysplasia or cancer (Hoff et al., 1986). On the other hand, Eide reported that the risk of 
developing cancer in a 1cm sized adenoma was 3% per year in a Norwegian population 
(Eide 1986). Stryker et al. showed the considerable malignant potential of large adenomas. 
Before the availability of colonoscopy, 226 patients who had large (>l cm) polyps detected 
with a barium enema, but who refused their removal by surgery were followed for up to 20 
years. Follow-up of these untreated patients showed that 37% of the polyps enlarged, 21 
invasive cancers developed at a polyp site and 11 cancers developed at another site. The 
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cumulative risk of cancer at 5, l0 and 20 years was 2.5, 8 and 24%, respectively (Stryker et al., 
1987).  
Based on a large volume of high-quality scientific evidence published during the past 
decade, the concept of the advanced adenoma as a surrogate biological indicator of the 
cancer risk has been established (Winawer and Zauber 2002). Although colorectal cancer 
would be a more ideal outcome measure, the advanced adenoma was adopted as an early 
outcome measure of efficacy because a much longer period of time would be required for 
conclusions to be drawn if cancer was used as the outcome measure.  
The recent guidelines for surveillance after polypectomy have adopted the concept of 
advanced adenoma and the guidelines have introduced the concept of risk stratification of 
patients at the time of polypectomy into those who are more likely or less likely to develop 
subsequent serious neoplasia (Bond 2000; Davila et al., 2006; Winawer et al., 2006; Sung et 
al., 2008; Arditi et al., 2009; Schmiegel et al., 2009; Cairns et al., 2010). However, a uniform 
definition of an advanced adenoma has not yet been clearly established, but most definitions 
include that advanced adenoma is an adenoma with high-grade dysplasia or an adenoma 
that is >10 mm in size or it has a villous component (≥25%), and advanced neoplasia is 
advanced adenoma and invasive cancer. A synchronous adenoma is an adenoma that is 
diagnosed at the same time as that of an index colorectal neoplasm. Thirty to fifty percent of 
colons with one adenoma will contain at least one other synchronous adenoma. A 
metachronous adenoma is an adenoma that is diagnosed at least 3 to 6 months after the 
diagnosis of a previous adenoma.  
2.2 Colonoscopy is the procedure of choice for post-polypectomy surveillance 
Colonoscopy is the preferred modality for post-polypectomy surveillance. It offers the 
advantages of complete visualization of the entire colon, detection and removal of polyps, 
and diagnostic sampling of cancers. An early controlled, single-blinded study that 
compared the accuracy between colonoscopy and a double contrast barium enema 
performed in the same patients demonstrated a sensitivity of double-contrast barium enema 
and colonoscopy for detecting polyps of 67% and 94%, respectively (Durdey et al., 1987; 
Winawer et al., 2000). 
Computed tomography (CT) colonography is now being studied for the surveillance of 
patients with colorectal cancer or polyps. CT colonography has already been shown to be 
more accurate than a double-contrast barium enema for detecting polyps as well as having 
similar or more accuracy than colonoscopy for detecting large (≥ 1cm) polypoid adenomas, 
although the accuracy rapidly drops for medium-sized and small polyps (Kim et al. 2007; 
Benson et al., 2010). However, a major limitation of CT colonography compared with 
conventional colonoscopy is that, as with a barium enema, this modality has only 
diagnostically usefulness. Whenever a suspicious lesion or clinically significant neoplasia is 
found, the patient must undergo a subsequent colonoscopy to confirm and resect the lesion. 
Considering a patient with one colorectal adenoma has a 30-50% likelihood of developing 
new metachronous adenoma, the need to do two expensive tests would make such 
surveillance costly and inconvenient.  
3. Quality of baseline colonoscopy 
The quality of the baseline colonoscopy is important to clearly visualize synchronous and to 
predict the risk for subsequent neoplasia. To assess the quality of colonoscopy, several direct 
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and indirect quality measures have been proposed, including the bowel preparation status 
and other parameters for the performance of colonoscopy, and the parameters include the 
cecal intubation rate, the withdrawal time and the adenoma detection rate. Until now, there 
is a lack of objective data related to any of these measures to assess the most important 
outcome of screening colonoscopy, which is the subsequent incidence of advanced adenoma 
or colorectal cancer. However, the US Multi-Society Task Force defined a high-quality 
colonoscopy as a colonoscopy that reaches the cecum, it has little fecal residue and it has a 
minimum time of withdrawal from the cecum of 6–10 minutes (Rex et al., 2002). With the 
current recommendations suggesting that the postpolypectomy surveillance colonoscopy 
intervals should lengthen to improve the efficacy of the utilization of resources, the need for 
high-quality colonoscopy is of paramount importance. 
3.1 Bowel preparation  
Even small amounts of fecal material can obscure colorectal adenomas, advanced adenoma 
and cancers. In a retrospective evaluation of more than 5,000 colonoscopies performed over 
a 3.5-year period, Leaper et al. identified 17 patients with a missed colorectal cancer. Poor 
bowel preparation was noted in 6 of these patients, which suggested that the cleansing 
quality may have an impact on the diagnostic yield during a colonoscopy.(Leaper et al., 
2004) In a larger retrospective study, Harewood et al. analyzed the impact of the adequacy 
of bowel-preparation on the detection of polypoid lesions for approximately 93,000 
colonoscopies recorded in the Clinical Outcome Research Initiative database. Suspected 
neoplasms were identified in 26,490 colonoscopies (29%) overall, with higher detection rates 
for those cases with adequate preparation (rated excellent or good by the endoscopist) 
versus those cases with inadequate preparation (fair or poor) (29% vs. 26%, respectively, 
P<.0001). Although significant lesions (a polyp >9 mm or a mass lesion) were detected in 
approximately 7% of the colonoscopies, regardless of preparation quality (P = .82), lesions ≤ 
9 mm were more likely to be detected when the bowel preparation was adequate versus 
inadequate (22% vs. 19%, respectively P<.0001) (Harewood et al., 2003). Although the risk of 
advanced neoplasia increases with polyp size, high-grade dysplasia and carcinoma can 
occur in adenomas of any size. High-grade dysplasia was reported in 0.9 to 3.4% of the 
adenomas ≤5 mm and in 3.6 to 12.5% of the adenomas 5 or 6 mm to 10 mm in size.  
In addition, a prospective study by Froehlich et al. reported that the detection of neoplasia, 
including polyps of any size as well as large lesions (>10 mm), was associated with the 
quality of bowel preparation; polyps were detected in 29% of the patients with high-quality 
cleansing versus 24% of the patients with low-quality cleansing (P<.007). Identifying polyps 
of any size significantly depended on the cleansing quality (intermediate-quality vs. low-
quality preparation: OR: 1.73, 95% CI: 1.28-2.36; high-quality vs. low-quality preparation: 
OR: 1.46, 95% CI: 1.11-1.93). For polyps ≥ 10 mm in size, the OR was 1.83 (95% CI: 1.11-3.05) 
for intermediate-quality cleansing and 1.72 (95% CI: 1.11-2.67) for high-quality cleansing, 
respectively (Froehlich et al., 2005). Furthermore, flat and depressed lesions are rarer than 
protruding lesions, but they more frequently contain advanced neoplasia, including 
invasive carcinoma. Parra-Blanco et al. reported that the number of flat lesions detected in 
patients with inadequate bowel preparation was significantly lower than that in patients 
with adequate bowel preparation (9 vs. 28, respectively, P = .002) (Parra-Blanco et al., 2006).  
3.2 Adenoma detection rate 
In one of the most important studies of the past year, Kaminski et al. demonstrated that the 
adenoma detection rate for individual endoscopists, which is the most commonly proposed 
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proxy for quality in colorectal cancer screening, is indeed an independent predictor of the 
risk for subsequent colorectal cancer after screening colonoscopy. Among 45,026 patients 
who were enrolled in a national screening colonoscopy program, 42 interval colorectal 
cancers were identified by a search of national and regional cancer registries in Poland. Most 
patients with cancer had no family history of colorectal cancer (83.3%) and no polyps 
identified on the screening examination (92.9%). Only one cancer (2.4%) was attributed to 
incomplete polyp resection at the time of the screening procedure. The 186 contributing 
endoscopists had a median adenoma detection rate of 12.2%. The 42 interval cancers 
occurred after procedures by 32 endoscopists, with three endoscopists contributing three 
cases each and four contributing two cases each. A strong association between the adenoma 
detection rates and the subsequent identification of interval cancers was noted (P=0.008), 
with significant hazard ratios for those endoscopists with adenoma detection rates of less 
than 11%, 11–14.9%, and 15–19.9%, as compared with those endoscopists with adenoma 
detection rates over 20% (P = 0.02 for all comparisons). The adenoma detection rate is an 
independent predictor of the risk of interval colorectal cancer after screening colonoscopy 
(Kaminski et al., 2010). 
3.3 Withdrawal time  
Numerous published series have assessed correlations between the proportion of patients 
with identified polyps or adenomas and the colonoscopic withdrawal time. Barclay et al 
compared the rates of detecting neoplastic lesions among 12 gastroenterologists who had 
mean colonoscopic withdrawal times of less than 6 minutes with the rates of those 
gastroenterologists who had mean withdrawal times of 6 minutes or more. There were large 
differences among the gastroenterologists in the adenoma detection rates (9.4% to 32.7%) 
and in their withdrawal times of the colonoscope from the cecum to the anus (range: 3.1 to 
16.8 minutes). As compared with the colonoscopists with mean withdrawal times of less 
than 6 minutes, those colonoscopists with mean withdrawal times of 6 minutes or more had 
higher rates of detecting any neoplasia (28.3% vs. 11.8%, respectively P<0.001) and advanced 
neoplasia (6.4% vs. 2.6%, respectively, P=0.005) (Barclay et al., 2006). Furthermore, most 
series have also shown significant associations between the speed of withdrawal and the 
polyp or adenoma detection rates, and some series have shown associations between the 
speed of withdrawal and the detection of high-risk lesions, based on size or histology.   
3.4 Cecal intubation  
Cecal intubation is defined as insertion of the colonoscope tip into the cecal caput so that the 
medial wall of the cecum proximal to the ileocecal valve can be fully inspected. The targets 
for successful cecal intubation rates are 90% for all colonoscopies and 95% for screening 
colonoscopies. However, because almost all the previous studies excluded the colonoscopy 
with incomplete cecal intubation from analysis, there is very scare information about the 
effect of incomplete colonoscopy on the detection of advanced neoplasia with surveillance 
colonoscopy. In the Funen adenoma follow-up study by Jorgensen and colleagues, the 53 
patients with incomplete initial colonoscopy had at least 1 complete colonoscopy during 
surveillance; advanced neoplasia was detected in 6 of these patients. The area of new 
advanced neoplasia had been covered by the initially incomplete colonoscopy in three of the 
six patients, and later the area was covered in four of the six, before advanced neoplasia was 
detected. Newly detected advanced neoplasia was associated with incomplete colonoscopy 
at the initial examination (OR: 2.5; 95% CI: 1.0-6.3) (Jorgensen et al., 1995). 
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3.5 Completeness of polypectomy  
In the absence of magnifying endoscopy combined with dye spraying, it is often not possible 
to determine the histological type of a polyp by endoscopic inspection. Diminutive polyps 
(<5 mm) may be indistinguishable from hyperplastic polyp and adenomas. In addition, the 
unusual large hyperplastic polyp may mimic an adenoma. For this reason, all polyps should 
be considered for removal. Magnifying endoscopy is likely to become increasingly available 
and an endoscopic diagnosis may reduce the requirement to remove minute polyps in 
patients with multiple lesions. Diminutive polyps may be too numerous to be completely 
cleared. In subjects with multiple small polyps, a sample of at least three should be biopsied 
for histological study. The cancer risk is related to the number of adenomas, so the 
documentation of the polyp type has prognostic value and surveillance implications. Hot 
biopsy and electrocoagulation have been used to eradicate diminutive polyps, but 
destruction of the specimen makes it difficult to histologically review it, and hot biopsy and 
electrocoagulation may leave residual polyp behind. Cold snare polypectomy is an effective 
alternative and it does not compromise the histology(Deenadayalu and Rex 2005). 
Lesions less than 2 cm in diameter can readily be transected with one application of the 
snare with submucosal injection. Inclusion of a small portion of normal mucosal adjacent to 
the confines of the polyp does not pose a problem, providing that this portion of normal 
mucosa is also resting on the submucosal fluid-filled bleb. However, sessile polyps greater 
than 2cm in diameter may require piecemeal removal, but this will make histological 
evaluation difficult or it may be impossible to completely remove them in a piecemeal 
fashion. Residual neoplastic tissue has been reported in up to one-third of cases after 
piecemeal resection of sessile polyps greater than 2cm in diameter. The area may be tattooed 
with sterile India ink to facilitate follow-up evaluation. Tattooing will also identify the site 
for subsequent surgical resection. A repeat clearing colonoscopy to insure complete 
polypectomy is essential after piecemeal resection of large sessile polyps. Such polyps often 
contain appreciable amounts of villous tissue with a high malignant potential and they tend 
to recur locally after colonosoopic resection even in cases where the initial polypcctomy 
appeared to be complete. A repeat clearing colonoscopy should be performed in 3-6 months 
to confirm that the resection was complete (Winawer et al., 2006; Cairns et al., 2010). In order 
to decrease the incidence of recurrent polyp at the polypectomy site, the base and edges of 
the polyp can be treated with a thermal modality. Although many endoscopists treat small 
residual fragments of adenoma following removal of large polyps with a thermal modality, 
this has not been studied for any device except the argon plasma coagulator (Zlatanic et al., 
1999). If polyp tissue persists after two or three examinations, then patients with low 
surgical morbidity should usually be referred for surgical resection. When patients are 
found to have these large sessile polyps, they need to be educated at the time of the initial 
diagnosis about the importance of complying with the entire course of management and 
follow-up. Most experienced colonoscopists have witnessed tragic cases in which a patient 
was partially treated by piecemeal snare polypectomy and was then lost to follow-up, and 
the patient returned later with an advanced cancer at the polyp site.  
4. Predictors of subsequent advanced adenomas 
The increased risk of recurrent adenomas after polypectomy is the result of lesions missed 
during the initial colonoscopy as well as a true increased risk of developing de-novo 
neoplastic lesions due to environmental and genetic risk factors that are particular to the 
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patient. In other words, the characteristics of initial adenoma and the patient serve as a 
marker for an increased risk of colorectal neoplasia. Although multiple studies have tried to 
identify the risk factors for metachronous neoplasia at the time of surveillance, the studies 
differed with respect to the classification levels of the risk factors and on the definition of 
advanced neoplasia. In addition, the studies also covered different periods of follow-up 
evaluation and they used different measures of effect such as ORs, relative risks, hazard 
ratios and standardized incidence ratios. To clarify these issues, Martinez and colleagues 
published the pooled analysis using individual data from 8 prospective studies (The 
Antioxidant Polyp Prevention Study, National Polyp Study, Calcium Polyp Prevention 
Study, Wheat Bran Fiber study, Veterans Affairs Cooperative Study, Aspirin Folate Trial 
and Ursodeoxycholic Acid study) that included 9167 men and women aged 22 to 80 with 
previously resected colorectal adenomas to quantify their risk of developing subsequent 
advanced adenoma or cancer, as well as to identify factors associated with the development 
of advanced colorectal neoplasia during surveillance (Martinez et al., 2009).  
4.1 Characteristics of baseline adenomas 
4.1.1 Multiplicity 
Multiplicity at baseline has been shown to predict subsequent detection of advanced 
adenomas. The pooled analysis of prospective studies showed that the number of adenomas 
at baseline was related to an increased risk (OR: 1.32, 95% CI: 1.25–1.40) for advanced 
adenomas at the time of surveillance. Of the randomized controlled trials, with excluding 
the studies included in the pooled analysis, Funen’s adenoma follow-up study and the 
European fiber and calcium study showed that multiplicity conferred an increased risk for 
advanced neoplasia at the time of surveillance. The Erlangen Registry of Colorectal Polyps 
by Nusko and colleagues showed that individuals with 2 or more adenomas at baseline 
were more likely than those with 1 adenomas at baseline to have an adenoma detected at the 
time of surveillance (OR: 1.54, 95% CI: 1.12–2.12).  
The observational prospective cohort studies also showed that multiplicity was a risk factor 
for subsequent advanced adenomas and cancer. Noshirwani and colleagues reported that 
the number of adenomas at baseline was related to an increased risk (OR: 1.25, 95% CI: 1.13–
1.38) for advanced adenomas at surveillance in a cohort from the Cleveland Clinic. 
However, the Study of Colonoscopy Utilization described by Pinsky and Bertario et al. 
failed to show a significant association between baseline multiplicity and the detection of 
advanced adenoma at the time of follow-up evaluation.  
 
Study  Number of 
index adenoma  
Total 
patients 
(N) 
Patients with 
Metachronous  
Advanced 
Neoplasia (N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Jorgensen (The Funen 
Adenoma Follow-up 
Study) 1995 
1 not mentioned 1 
2 not mentioned 1.3 (0.6-3.0) 
≥3 not mentioned 3.0 (1.2-7.1) 
Noshirwani 
(Cleveland Clinic 
Foundation Adenoma 
Registry) 2000 
per 1 increase   697 63 1.25 (1.13-1.38) 
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Nusko (Erlangen 
Registry of Colorectal 
Polyps) 2002 
1 not mentioned 1 
≥ 2 not mentioned 1.54 (1.12–2.12) 
Bertario 2003 1 736 7 1 
≥ 2 350 7 2.0(0.7–5.8)  
Bonithon-Kopp 
(European Fiber- 
Calcium Intervention 
trial) 2004 
1 360 18 1 
2 109 8 1.4 (0.59–3.51) 
≥ 3 83 15 3.6 (1.64–7.89) 
Martinez (Pooled 
anaylsis) 2009 
1 5465 497 1 
2 2054 271 1.39 (1.17–1.66) 
3 890 146 1.85 (1.46–2.34) 
4 326 68 2.41 (1.71–3.40) 
≥5 377 94 3.87 (2.76–5.42) 
Pinsky (Study of 
Colonoscopy 
Utilization) 2009 
1–2 small 
tubular 
adenoma 
not mentioned 1 
≥ 3 small 
tubular 
adenoma 
not mentioned 1.5 (0.8–2.6) 
The below studies were included in the pooled analysis (Martinez et al. 2009) 
Winawer (National 
Polyp Study) 1993 
1 541 6 1 
2 200 4 1.5 (0.4-5.6) 
≥ 3 197 18 6.9 (2.6-18.3) 
van Stolk (Antixoidant 
Polyp Prevention 
Trial) 1998 
1 or 2 393 13 1 
≥ 3 84 5 1.13 (0.40–3.18) 
Martinez (Wheat bran 
fiber trial) 2001 
1 742 86 1 
2 284 28 0.76 (0.43–1.36) 
≥3 261 32 1.01 (0.54–2.10) 
Table 1. Multiplicity of adenoma as a risk factor for advanced neoplasia at surveillance 
4.1.2 Size 
An adenoma size larger than 1 cm also was shown to predict metachronous advanced 
adenomas in a pooled analysis of prospective studies by Martinez (OR, 1.68; 95% CI, 1.39-
2.02). However, other randomized controlled trials, including Funen’s adenoma follow-up 
study and the European fiber and calcium study, did not find adenoma size at baseline to be 
an independent predictor of advanced neoplasia at the time of surveillance. Adenoma size 
was important in the prospective observational cohort studies that assessed advanced 
neoplasia. Noshirwani’s study, the Erlangen Registry of Colorectal Polyps and the Study of 
Colonoscopy Utilization showed that a baseline adenoma of 1 cm or larger, as compared 
with a baseline adenoma 1cm or smaller, conferred an OR of 3.68 (95% CI: 2.01-6.76), 1.81 
(95% CI: 1.42-2.31) and 1.5 (95% CI: 1.03–2.3), respectively, for subsequent advanced 
neoplasia. Bertario found that patients with adenomas larger than 2 cm, as compared with 
adenomas 2 cm or smaller, at baseline had a hazard ratio of 4.0 (95% CI: 1.1–14.4) for the 
development of follow-up advanced adenomas.  
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Study  Size of index 
adenoma (mm) 
Total 
patients 
(N) 
Patients with 
Metachronous  
Advanced 
Neoplasia (N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Jorgensen (The Funen 
Adenoma Follow-up 
Study) 1995 
≤5  not mentioned 1 
6-10  not mentioned 1.2 (0.5-2.9) 
>10  not mentioned 1.2 (0.5-2.9) 
Noshirwani 
(Cleveland Clinic 
Foundation Adenoma 
Registry) 2000 
< 10 not mentioned 1 
≥ 10  not mentioned 3.68 (2.01-6.76) 
Nusko (Erlangen 
Registry of Colorectal 
Polyps) 2002 
≤10 not mentioned 1 
> 10 not mentioned 1.81 (1.42–2.31) 
Bertario 2003 ≤10 700 6 1 
10-20 256 4 1.9 (0.5–6.6) 
> 20 107 4 4.0 (1.1–14.4) 
Bonithon-Kopp 
(European Fiber- 
Calcium Intervention 
trial) 2004 
<10 243 19 1 
≥ 10 309 22 1.06 (0.54–2.06) 
Martinez (Pooled 
anaylsis) 2009 
<5 2540 209 1 
5-10 3115 287 1.17 (0.95–1.42) 
10-20 2487 415 2.27 (1.84–2.78) 
≥ 20  672 138 2.99 (2.24–4.00) 
pooled not mentioned 1.56 (1.39-1.74) 
Pinsky (Study of 
Colonoscopy 
Utilization) 2009 
<10 not mentioned 1 
≥10 TA not mentioned 1.5 (1.03–2.3) 
The below studies were included in the pooled analysis (Martinez et al. 2009) 
Winawer (National 
Polyp Study) 1993 
≤ 5 228 3 1 
6-10 354 8 1.3 (0.3-5.2) 
> 10 356 17 2.2 (0.6-7.8) 
van Stolk (Antixoidant 
Polyp Prevention 
Trial) 1998 
< 10 258 11 1 
≥ 10  219 7 0.49 (0.16–1.51) 
Martinez (Wheat bran 
fiber trial) 2001 
< 5  395 36 1 
6–10 543 52 0.88 (0.52–2.14) 
10 349 58 2.27 (1.25–4.14) 
Table 2. Size of adenoma as a risk factor for advanced neoplasia at the time of surveillance 
4.1.3 Histology 
The histologic type of adenoma at baseline also was shown to predict metachronous 
advanced adenomas in a pooled analysis of prospective studies by Martinez (OR: 1.40, 95% 
CI: 1.17-1.68). However, in the randomized trials, the histologic type of adenoma at baseline 
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was not a significant predictor of advanced neoplasia. In the observational cohorts, villous 
or tubulovillous adenoma was a significant predictor of advanced neoplasia in the Study of 
Colonoscopy Utilization, but not in the study by Norshirwani.  
 
Study  Histology of 
adenoma at the 
index polyp 
Total 
patients 
(N) 
Patients with 
Metachrono
us  
Advanced 
Neoplasia 
(N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Jorgensen (The Funen 
Adenoma Follow-up 
Study) 1995 
Tubular not mentioned 1 
Tubulovillous not mentioned 1.2 (0.6-2.7) 
Noshirwani 
(Cleveland Clinic 
Foundation Adenoma 
Registry) 2000 
Tubular not mentioned 1 
Others not mentioned 1.37 (0.72-2.62) 
Bertario 2003 Tubular 772 10 1 
Tubulovillous 205 3 1.5 (0.4–5.6) 
Villous 80 1 1.2 (0.2–10.2) 
Bonithon-Kopp 
(European Fiber- 
Calcium Intervention 
trial) 2004 
Tubular 455 31 1 
Tubulovillous/villo
us 
97 10 1.67 (0.76–3.67) 
Martinez (Pooled 
anaylsis) 2009 
Tubular    7268 749 1 
Tubulovillous/villo
us 
1899 336 1.28 (1.07–1.52) 
Pinsky (Study of 
Colonoscopy 
Utilization) 2009 
Tubular not mentioned 1 
Tubulovillous/villo
us 
not mentioned 2.2 (1.5–3.1) 
The below studies were included in the pooled analysis (Martinez et al. 2009) 
Martinez (Wheat bran 
fiber trial) 2001 
Tubular 842 92 1 
Tubulovillous 317 41 1.10 (0.64–1.87) 
Villous 59 9 0.41 (0.15–1.13) 
Unspecified/incipie
nt 
69 4 0.47 (0.09–2.62) 
Lieberman (VA 
Cooperative Study 
Group 380) 2007 
No neoplasia 298 7 1 
Villous adenoma 81 13 6.05 (2.48-14.71) 
Table 3. Tubulovillous/villous adenoma as a risk factor for advanced neoplasia at the time 
of surveillance 
4.1.4 Degree of dysplasia 
By definition, all adenomas have some level of dysplasia. In the past, dysplasia has been 
classified as mild, moderate, severe or carcinoma in situ. Currently, severe dysplasia or 
carcinoma in situ is considered the equivalent of high-grade dysplasia and mild or moderate 
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dysplasia is considered the equivalent of low-grade dysplasia. High-grade dysplasia at 
baseline was not a significant predictor of advanced neoplasia in the pooled analysis of 
prospective studies (OR: 1.08, 95% CI: 0.82-1.41) and randomized controlled studies. 
However, high-grade dysplasia is related to a larger adenoma size and villous component at 
baseline. Although the VA Cooperative Study by Lieberman and colleagues was included in 
the pooled analysis, the VA Cooperative Study determined that 10.9% of the patients with 
high-grade dysplasia in adenomas of any size at baseline had advanced neoplasia over the 
5-year surveillance period, as compared with 0.6% in those with tubular adenomas less than 
1.0 cm in size and that lacked high-grade dysplasia.  
 
Study  Degree of atypia of 
the index polyp 
Total 
patients 
(N) 
Patients with 
Metachrono
us  
Advanced 
Neoplasia 
(N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Jorgensen (The Funen 
Adenoma Follow-up 
Study) 1995 
Mild not mentioned 1 
Moderate not mentioned 1.0 (0.4-2.2) 
Severe not mentioned 2.1 (0.6-7.1) 
Bertario 2003 Low/moderate 1050 11 1 
Severe 36 1 3.3 (0.7–15.5) 
Bonithon-Kopp 
(European Fiber- 
Calcium Intervention 
trial) 2004 
Mild  308 17 1 
Moderate/Severe  244 24 1.86 (0.96–3.64) 
Martinez (Pooled 
anaylsis) 2009 
Low grade 
dysplasia 
6485 719 1 
High grade 
dysplasia 
683 118 1.05 (0.81–1.35) 
The below studies were included in the pooled analysis (Martinez et al. 2009) 
Lieberman (VA 
Cooperative Study 
Group 380) 2007 
no neoplasia 298 7 1 
High grade 
Dysplasia 
46 8 6.87 (2.61-18.07) 
CRC 23 8 13.56 (5.54–
33.18) 
Table 4. High-grade dysplasia of adenoma as a risk factor for advanced neoplasia at the time 
of surveillance 
4.1.5 Location 
The pooled analysis by Martinez reported that a proximal adenoma at baseline was 
associated with an increased risk for subsequent advanced adenomas. The OR was 1.68 
(95% CI: 1.39–2.02) for any proximal adenomas at baseline vs distal adenomas only at 
baseline. Similarly, Bonithon-Kopp reported an OR of 2.63 (95% CI: 1.31–5.3) for subsequent 
advanced neoplasia for patients with a proximal location of baseline adenomas compared 
with no proximal location of baseline adenomas. In the observational cohort study of 
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Pinsky, the risk of metachronous neoplasia at surveillance was significant higher for 
patients with adenomas on the proximal colon only at baseline than for patients with 
adenomas on the distal colon only.  
 
Study  Location of index 
adenoma 
Total 
patients 
(N) 
Patients with 
Metachronous  
Advanced 
Neoplasia (N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Bertario 2003 Right colon 317 2 0.7 (0.1–7.6) 
Left colon 641 11 2.0 (0.3–16.1) 
Rectum  128 1 1 
Bonithon-Kopp 
(European Fiber- 
Calcium Intervention 
trial) 2004 
No distal location 50 2 1 
Distal location 502 39 3.37 (0.74–15.3) 
No proximal 
location 
438 23 1 
Proximal location 114 18 2.63 (1.31–5.3) 
Martinez (Pooled 
anaylsis) 2009 
Distal  4434 395 1 
Proximal only 2620 330 Any proximal: 
1.68 (1.43–1.98) Both  1754 325 
Pinsky (Study of 
Colonoscopy 
Utilization) 2009 
Distal colon only not mentioned 1 
Proximal colon 
only 
not mentioned 1.8 (1.1–2.7) 
The below studies were included in the pooled analysis (Martinez et al. 2009) 
Martinez (Wheat 
bran fiber trial) 2001 
Distal colon 701 68 1 
Proximal colon 349 44 1.65 (1.02–2.67) 
Both 234 33 2.69 (1.34–5.42) 
Table 5. Location of adenoma as a risk factor for advanced neoplasia at the time of 
surveillance 
4.1.6 Shape of adenoma 
The flat adenoma may be a more aggressive pathway in colorectal carcinogenesis. However, 
O’Brien reclassified the histopathologically sessile adenomas from the National Polyp Study 
cohort as flat (defined as an adenoma thickness ≤1.3 mm and <2× the normal mucosa 
thickness) or polypoid and O’Brien compared between the initial and surveillance 
pathology. Flat adenomas identified in the National Polyp Study cohort at baseline were not 
associated with a higher risk for advanced adenomas at the time of surveillance. 
4.1.7 Serrated polyps 
Recent studies have shown that, aside from classic adenomas, serrated polyps (sessile 
serrated adenomas, mixed mucosal polyps and traditional serrated adenomas) are of 
special significance. These lesions are also associated with an elevated risk of malignant 
degeneration via the so called serrated cancer development pathway (Hiraoka et al., 
2010; Leggett et al., 2010; Lu et al., 2011). However, in contrast, after the removal of 
singular hyperplastic polyps, no special follow-up examination is required (Imperiale et 
al., 2008). 
www.intechopen.com
 
Post-Polypectomy Colonoscopy Surveillance 
 
109 
4.2 Patient’s characteristics 
4.2.1 Age 
Pooled analysis and several prospective observational studies by Bertario and Yamaji 
reported an increasing risk for subsequent neoplasia with increasing age. However, age was 
frequently used as a control variable in the analyses without an explicit risk factor presented 
for the age effect.  
 
 
Study  Age at the time of 
polypectomy 
(years) 
Total 
patients 
(N) 
Patients with 
Metachronous  
Advanced 
Neoplasia (N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Jorgensen (The 
Funen Adenoma 
Follow-up Study) 
1995 
≤60 not mentioned 1 
>60 not mentioned 1.5 (0.8-3.0) 
Noshirwani 
(Cleveland Clinic 
Foundation 
Adenoma Registry) 
2000 
per 10-year 
increase 
not mentioned 1.10 (0.82-1.45) 
Bertario 2003 <60 503 5 1 
60–69 339 5 2.1 (0.6–7.5) 
≥70 244 4 4.1 (1.0–16.0) 
Yammaji 2004 < 40 154 6 1 
40-49 804 52 2.3 (0.7–7.6) 
50-59 2397 213 3.6 (1.1–12) 
≥ 60  62 12 5.5 (1.6–19) 
Martinez (Pooled 
anaylsis) 2009 
< 40 154 6 0.41 (0.18–0.94) 
40-49 804 52 0.67 (0.48–0.93) 
50-59 2397 213 1 
60-69 3676 460 1.39 (1.16–1.68) 
70-79 2074 328 1.72 (1.40–2.11) 
≥ 80  62 12 2.70 (1.31–5.57) 
< 40 154 6 0.41 (0.18–0.94) 
Laiyemo 2009, USA ≤65 not mentioned 1 
> 65 not mentioned 1.3 (0.7–2.5) 
 
Table 6. Age at the time of polypectomy as a risk factor for advanced neoplasia at the time of 
surveillance 
4.2.2 Gender 
Gender was also frequently used as a control variable in the analyses without an explicit risk 
factor presented for the gender effect. The pooled analysis and the observational study by 
Bertario reported an increased risk for males for advanced neoplasia at the time of 
surveillance.  
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Study  Gender Total 
patients 
(N) 
Patients with 
Metachronous  
Advanced 
Neoplasia (N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Jorgensen (The 
Funen Adenoma 
Follow-up Study) 
1995 
Female not mentioned 1 
Male not mentioned 1.1 (0.6-2.5) 
Noshirwani 
(Cleveland Clinic 
Foundation 
Adenoma Registry) 
2000 
Female not mentioned 1 
Male not mentioned 1.48 (0.74-2.93) 
Bertario 2003, Italy Female 487 2 1 
Male 599 12 6.5 (1.4–29.9) 
Yammaji 2004, Japan Female not mentioned 1 
Male not mentioned 0.9 (0.5–1.5) 
Martinez (Pooled 
anaylsis) 2009 
Female 2642 267 1 
Male 6525 815 1.40 (1.19–1.65) 
Laiyemo (Continued 
Follow-Up Study of 
the Polyp Prevention 
Trial) 2009 
Female not mentioned 1 
Male not mentioned 2.0 (0.9–4.6) 
Pinsky (Study of 
Colonoscopy 
Utilization) 2009 
Female not mentioned 1 
Male not mentioned 1.2 (0.9–1.8) 
Table 7. Gender as a risk factor for advanced neoplasia at the time of surveillance 
4.2.3 Family history of colorectal cancer in first degree relatives 
A family history of colorectal cancer in first degree relatives is an established risk factor for 
the development of colorectal cancer. However, few studies have specifically addressed the 
relationship between a family history and metachronous advanced adenomas in 
postpolypectomy patients. The Erlangen Registry of Colorectal Polyps reported that a 
parental history of colorectal cancer is associated with subsequent advanced neoplasia, but 
the pooled analysis, Bertario’s study and the Continued Follow-Up Study of the Polyp 
Prevention Trial by Laiyemo did not find a significant association between the subsequent 
advanced neoplasia and a family history of colorectal cancer in first degree relatives.  
4.2.4 History of previous polyps 
Both the pooled analysis and Bonithon-Kopp study noted that a history of polyps before the 
baseline adenoma was associated with an increased risk for advanced neoplasia at the time 
of surveillance. Although it is not always possible to determine whether prior polyps are 
adenomatous polyps, the presence of prior polyps can be considered as an additional risk 
factor.  
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Study  Family history of 
colorectal cancer 
Total 
patients 
(N) 
Patients with 
Metachronous  
Advanced 
Neoplasia (N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Nusko (Erlangen 
Registry of 
Colorectal Polyps) 
2002 
No not mentioned 1 
Yes not mentioned 2.32 (1.77–3.04) 
Bertario 2003, Italy No 787 10 1 
Yes 299 4 1.3 (0.4–4.1) 
Martinez (Pooled 
anaylsis) 2009 
No 6547 759 1 
Yes 2089 255 1.17 (0.99–1.38) 
Laiyemo (Continued 
Follow-Up Study of 
the Polyp Prevention 
Trial) 2009 
No not mentioned 1 
Yes not mentioned 1.0 (0.5–2.0) 
Table 8. A family history of colorectal cancer in first degree relatives as a risk factor for 
advanced neoplasia at the time of surveillance 
 
Study  History of previous 
polyp 
Total 
patients 
(N) 
Patients with 
Metachronous  
Advanced 
Neoplasia (N) 
Adjusted 
OR/RR/HR  
(95% CI) 
Bonithon-Kopp 
(European Fiber- 
Calcium Intervention 
trial) 2004 
No 468 29 not mentioned 
 Yes 84 12 
Martinez (Pooled 
anaylsis) 2009 
No 6941 722 1 
Yes 2057 329 1.76 (1.48–2.09) 
Table 9. A history of previous polyp as a risk factor for advanced neoplasia at the time of 
surveillance 
4.2.5 Race 
The pooled analysis of prospective studies by Martinez reported that the race of patients 
with polyp removal was associated with a different risk for subsequent advanced neoplasia. 
Compared to the white race, the black race showed an increased risk for subsequent 
advanced neoplasia (OR: 1.08, 95% CI: 0.79–1.47), whereas other races showed a tendency 
for a decreased risk for subsequent advanced neoplasia (OR: 0.83, 95% CI: 0.60–1.16). 
5. Risk stratification for the metachronous advanced adenoma risk  
The totality of evidence suggests that multiplicity (3 or more adenomas), size (1 cm or 
more), villous features, high-grade dysplasia, a proximal location and a history of previous 
polyp are the predictors of future advanced neoplasia. Race, age, gender and a family 
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history of colorectal cancer also may predict metachronous advanced neoplasia, but this has 
not been well studied. Analysis of the relative importance of each of these predictors is 
complicated by their interrelationships.  
The current guidelines from the major organizations, including the US Multi-Society Task 
Force on Colorectal Cancer (USMTF), the American College of Gastroenterology (ACG), the 
American Society of Gastrointestinal Endoscopy (ASGE), and the British Society of 
Gastroenterology (BSG), have accepted the risk stratification listed in Table 10 (Bond 2000; 
Davila et al., 2006; Winawer et al., 2006; Cairns et al., 2010). 
There is a consensus among many of the studies that the group at a lower risk for 
subsequent advanced neoplasia has only 1 or 2 tubular adenomas that are less than 1 cm in 
size and low-grade dysplasia and they are located only in the distal colon. In the 
colonoscopy based studies, the patients have been followed-up for only 5–6 years after 
colonoscopic polypectomy to assess their subsequent risk for neoplasia.   
 
Term Definition 
Low risk group 
All of the following: 
1 or 2 adenomas 
Size < 1 cm 
Tubular histology 
No high-grade dysplasia 
High risk group 
Any of the following: 
Multiple adenomas (≥ 3) 
Size ≥ 1 cm 
Villous or tubulovillous histology 
High-grade dysplasia 
 
Higher risk group 
Any of the following: 
>10 small adenomas 
Piecemeal resection of large sessile adenoma 
Table 10. Risk stratification for subsequent advanced neoplasia  
6. Post-polypectomy surveillance interval 
Based on risk stratification, the major organisations have suggested the post-polypectomy 
colonoscopy surveillance interval (Table11). All the guidelines rely on periodic colonoscopy 
as the primary method of surveillance. The surveillance interval is based on the risk of 
metachronous advanced neoplasia as predicted by the findings on initial colonoscopy. Most 
of the guidelines recommend repeat colonoscopy in 5–10 years for low-risk patients (only 
one or two small adenomas, <1 cm in size); for such patients, the BSG advises either repeat 
colonoscopy in 5 years or no surveillance at all (the patients can continue average-risk 
screening). For the patients at high risk (advanced neoplasm or 3–10 small adenomas), 
colonoscopy should be repeated in 3 years, with subsequent colonoscopies every 5 years if 
the preceding colonoscopy was negative. In most of the guidelines, an advanced neoplasm 
is defined as a villous or tubulovillous adenoma, an adenoma with intermediate-grade or 
high-grade dysplasia, or a tubular adenoma 1 cm in size or larger. The USMTF guidelines 
specify that the colonoscopy intervals can be extended to 10 years if the preceding 
colonoscopy did not show adenomas. In patients with numerous (>10) adenomas but there 
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was no overt adenomatous polyposis syndrome, colonoscopy should be repeated in less 
than 3 years, with the exact interval to be determined by the endoscopist. For patients with 
large sessile adenomas that are difficult to completely remove in one session, a repeat 
colonoscopy after a short interval (2–6 months) is recommended. Subsequent intervals are 
customized according to the level of suspicion for residual adenomatous tissue at the 
polypectomy site. If a sessile polyp is very extensive or it has high-grade dysplastic features, 
then surgical resection should be considered. After it is certain that all adenomatous tissue 
has been removed, surveillance with 3–5 year intervals can be resumed.  
 
 Organization First 
surveillance  
interval 
Second surveillance 
interval if surveillance 
colonoscopy shows no 
adenomas 
Low risk group 
1–2 tubular 
adenomas, <1cm and 
lowe-grade dysplasia 
USMTF 5–10 years  - 
ACG 5 years* 5 years 
ASGE No earlier than 5 
years 
No earlier than 5 years 
BSG 5 years or no 
surveillance 
No surveillance 
High risk group 
3-10 adenomas, ≥ 1 
cm, tubulovillous 
/villous adenoma or 
High-grade dysplasia 
USMTF 3 years 5 years 
ACG 3 years† 5 years 
ASGE 3 years No earlier than 5 years 
BSG 3 years‡ 3 years§ 
Higher risk group 
>10 small adenomas USMTF <3 years  
ACG - - 
ASGE <3 years 5 years 
BSG 1 year¶ 3 years‡ 
Large sessile 
adenoma 
USMTF 2–6 months Customised 
ACG 3–6 months - 
ASGE 2–6 months Customised 
BSG 3 month 1 year|| 
Abbreviation: US Multi-Society Task Force on Colorectal Cancer, USMTF; American College of 
Gastroenterology, ACG; American Society of Gastrointestinal Endoscopy, ASGE; British Society of 
Gastroenterology, BSG. 
*The ACG guidelines note that selected low-risk patients might not need surveillance at all, but they do 
not further elaborate. †The ACG guidelines consider patients with 1–2 small adenomas and a positive 
family history in a first-degree relative to be at intermediate risk. ‡The BSG guidelines define 
intermediate-risk patients as those with 3–4 small adenomas or at least one adenoma ≥1 cm in size. §The 
BSG guidelines recommend ceasing surveillance if two consecutive follow-up colonoscopies are 
negative. ¶The BSG guidelines define high risk patients as those with ≥5 adenomas or ≥3 adenomas with 
at least one of which is ≥1 cm in size. ||The BSG guidelines recommend repeating colonoscopy in 1 year 
after confirmation of complete removal, and then every 3 years. 
 
Table 11. Summary of the post-polypectomy guidelines 
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Over the past few decades, the recommended intervals between surveillance colonoscopies 
have been extended, on the basis of accumulating data that showed longer surveillance 
intervals are safe. For example, the National Polyp Study showed no difference in the 
adenoma risk between patients who had repeat colonoscopy at 1 year versus those who had 
colonoscopy at 3 years, while the Funen Adenoma Study showed no statistically significant 
difference in the adenoma recurrence rates at 4 years colonoscopy compared with 2 years 
colonoscopy. Depending on the patient’s and physician’s preference, surveillance may be 
discontinued if the life expectancy is under 10 years (USMTF) or if the patient is over 75 
years old (BSG). For most guidelines, the surveillance recommendations are relaxed after 
one or two negative follow-up colonoscopies. However, the ACG considers those patients 
with a history of adenomas to be at a lifelong risk for metachronous lesions and the ACG 
recommends colonoscopies at least every 5 years indefinitely. It is important to note that 
these surveillance interval recommendations are based on the assumption that the baseline 
colonoscopy is of high quality with good bowel preparation, thorough removal of polyps 
has been done, there is an adequate examination time and complete visualization of all 
colonic mucosa up to and including the caecum.  
Surveys have shown that the patients’ compliance with physicians’ recommendations for 
surveillance is high (up to 85%), and particularly in the presence of multiple or larger polyps 
(Klabunde et al., 2003; Mysliwiec et al., 2004; Kang et al., 2006). Also, patients are often 
interested in chemopreventive measures such as antioxidants, fiber, and calcium or other 
dietary supplements, although the efficacy of all these agents has not been unequivocally 
shown. The effect of surveillance colonoscopy on the quality of life has not been directly 
studied, although patients probably derive benefit if we extrapolate the results from quality-
of-life studies on screening colonoscopy. Unfortunately, many clinicians do not adhere to 
the surveillance guidelines and they often do colonoscopies more frequently than is 
recommended. This over-surveillance is probably due to concerns about missed lesions or 
interval cancers, which can occur even in patients who are under close surveillance. 
Improved adherence to guidelines could be achieved by the use of reminder devices and 
algorithms for continuous improvement. Other screening measures, such as the use of 
interval testing of faecal occult blood, might also allow practitioners to feel more 
comfortable with longer surveillance intervals (Bampton et al., 2005).  
7. Conclusion 
Identifying the high risk subjects is important, as is ensuring that the subjects accept and 
comply with the recommended surveillance program. Two important factors, in addition to 
the individual patient factors, have a profound effect on the cancer risk: these are the quality 
of performing the examination, and ensuring complete removal of large sessile lesions. In 
addition to the potentially therapeutic value of polyp removal, colonoscopy is an 
opportunity to identify a small, high risk group of patients who require careful surveillance 
to prevent the development of cancer. It is also an opportunity to identify a much larger 
group of patients who can be informed with some confidence that their cancer risk is low. 
The overall effectiveness of an adenoma surveillance program for preventing colorectal 
cancer depends on each colonoscopy being undertaken slowly, carefully and thoroughly 
with a fail-safe system in place for recalling the higher risk patients 
Further research will help define the best surveillance intervals, as well as the role of 
technical innovations such as CT colonography, chromoendoscopy and narrow-band 
imaging. 
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